预装载开窗胸主动脉支架治疗远端主动脉弓病变的多中心回顾性短期与中期结果分析
结果显示技术成功率99%,30天死亡率3.7%,主要卒中5.6%,脊髓缺血3.7%,中期生存和免于再干预率可接受。
要点
- f-TEVAR治疗远端主动脉弓病变技术成功率99%,围手术期结局可接受。
- 术后30天死亡率3.7%,主要卒中5.6%,脊髓缺血3.7%。
- 逆撕主动脉夹层发生率3/19(15.8%),均见于无既往主动脉手术的B型夹层动脉瘤患者。
核心结论
- f-TEVAR治疗远端主动脉弓病变可行,30天死亡率、卒中和脊髓缺血率结果良好。
主要发现
- 30天死亡率为3.7%(4例),主要卒中发生率为5.6%(6例),脊髓缺血发生率为3.7%(4例)。
- 随访期间Ia型内漏3.5%(4/104),Ib型内漏2.9%(3/104)。
- 1年、2年和3年生存率分别为93.2%、89.1%和84.4%,免于再干预率分别为92.1%、86.3%和73%。
- 逆撕主动脉夹层发生3例(其中2例致命),均见于无既往主动脉手术的B型夹层动脉瘤患者(3/19,15.8%)。
临床怎么用
- 对于远端主动脉弓病变,f-TEVAR可作为可行治疗选择,需注意术中导丝缠绕和逆撕风险。
局限性
- 回顾性研究设计,样本量有限,随访时间中位仅12个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine short and midterm outcomes of a pre-loaded fenestrated thoracic endograft (f-TEVAR) for exclusion of distal aortic arch pathologies. METHODS: This was a multicentre, retrospective study including consecutive patients from six experienced European vascular centres undergoing f-TEVAR for distal arch pathologies. Primary endpoints included peri-operative mortality and peri-operative stroke and/or spinal cord ischaemia rates. Secondary outcomes were technical success and mid to late events, including death and re-interventions. Statistical analysis was performed with SPSS 26. Mid to late term events were calculated using Kaplan-Meier survival analysis. RESULTS: One hundred and eight patients were included (mean age 68 ± 11 years, 70% men). A total of 38% (n = 42) had a prior history of aortic dissection, and 24% (n = 26) prior aortic surgery. The mean aneurysm diameter was 59 ± 12 mm and the most frequent indication for treatment was post-dissection aneurysms (n = 42, 39%). Technical success was 99% (n = 107) despite intra-operative wire entanglement occurring in 29% (n = 31). The 30 day mortality rate was 3.7% (n = 4), with a 5.6% major stroke incidence (n = 6) and 3.7% (n = 4) spinal cord ischaemia rate. Three cases of retrograde dissection occurred (two of which were fatal), all in post-type B dissecting aneurysm patients without prior aortic surgery (three of 19, 15.8%). Median follow up was 12 months (range, 1 - 26). Endoleaks were documented during follow up, with 3.5% type Ia (4/104) and 2.9% type Ib (3/104) as a result of persistent false lumen perfusion. The one, two, and three year survivals and freedom from re-intervention rates were 93.2% and 92.1%, 89.1% and 86.3%, and 84.4% and 73%, respectively. CONCLUSION: This multicentre study shows that treatment of the distal aortic arch by f-TEVAR is feasible, with promising 30 day mortality, stroke, and spinal cord ischaemia rates.
引用
- Tsilimparis N, Prendes CF, Rouhani G, et al. Pre-Loaded Fenestrated Thoracic Endografts for Distal Aortic Arch Pathologies: Multicentre Retrospective Analysis of Short and Mid Term Outcomes. Eur J Vasc Endovasc Surg. 2021. PMID: 34629278. doi:10.1016/j.ejvs.2021.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。